Hopes dim for Medtronic hypertension treatment after FDA panel rebuff

Medtronic’s efforts to bring a new, device-based treatment for controlling high blood pressure to the U.S. have met with repeated disappointments over the past decade, and a number of analysts are growing more skeptical about its chances for success.